Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:17697049rdf:typepubmed:Citationlld:pubmed
pubmed-article:17697049lifeskim:mentionsumls-concept:C0085103lld:lifeskim
pubmed-article:17697049lifeskim:mentionsumls-concept:C0070798lld:lifeskim
pubmed-article:17697049lifeskim:mentionsumls-concept:C0085732lld:lifeskim
pubmed-article:17697049lifeskim:mentionsumls-concept:C1167622lld:lifeskim
pubmed-article:17697049lifeskim:mentionsumls-concept:C0205263lld:lifeskim
pubmed-article:17697049lifeskim:mentionsumls-concept:C0679622lld:lifeskim
pubmed-article:17697049lifeskim:mentionsumls-concept:C1880177lld:lifeskim
pubmed-article:17697049lifeskim:mentionsumls-concept:C0205314lld:lifeskim
pubmed-article:17697049pubmed:issue5lld:pubmed
pubmed-article:17697049pubmed:dateCreated2007-8-16lld:pubmed
pubmed-article:17697049pubmed:abstractTextProtein kinase C-epsilon (epsilonPKC) induces neurite outgrowth in neuroblastoma cells but molecular mechanism of the epsilonPKC-induced neurite outgrowth is not fully understood. Therefore, we investigated the ability of phosphatidylinositol 4,5-bisphosphate (PIP(2)) binding of epsilonPKC and its correlation with the neurite extension. We found that full length epsilonPKC bound to PIP(2) in a 12-omicron-tetradecanoylphorbol-13-acetate dependent manner, while the regulatory domain of epsilonPKC (epsilonRD) bound to PIP(2) without any stimulation. To identify the PIP(2) binding region, we made mutants lacking several regions from epsilonRD, and examined their PIP(2) binding activity. The mutants lacking variable region 1 (V1) bound to PIP(2) stronger than intact epsilonRD, while the mutants lacking pseudo-substrate or common region 1 (C1) lost the binding. The PIP(2) binding ability of the V3-deleted mutant was weakened. Those PIP(2) bindings of epsilonPKC, epsilonRD and the mutants well correlated to their neurite induction ability. In addition, a chimera of pleckstrin homology domain of phospholipase Cdelta and the V3 region of epsilonPKC revealed that PIP(2) binding domain and the V3 region are sufficient for the neurite induction, and a first 16 amino acids in the V3 region was important for neurite extension. In conclusion, epsilonPKC directly binds to PIP(2) mainly through pseudo-substrate and common region 1, contributing to the neurite induction activity.lld:pubmed
pubmed-article:17697049pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17697049pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17697049pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17697049pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17697049pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17697049pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17697049pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17697049pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17697049pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17697049pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17697049pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17697049pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17697049pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17697049pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17697049pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17697049pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17697049pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17697049pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17697049pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17697049pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17697049pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17697049pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17697049pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17697049pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17697049pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17697049pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17697049pubmed:languageenglld:pubmed
pubmed-article:17697049pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17697049pubmed:citationSubsetIMlld:pubmed
pubmed-article:17697049pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17697049pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17697049pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17697049pubmed:statusMEDLINElld:pubmed
pubmed-article:17697049pubmed:monthSeplld:pubmed
pubmed-article:17697049pubmed:issn0022-3042lld:pubmed
pubmed-article:17697049pubmed:authorpubmed-author:SaitoNaoakiNlld:pubmed
pubmed-article:17697049pubmed:authorpubmed-author:ShiraiYasuhit...lld:pubmed
pubmed-article:17697049pubmed:authorpubmed-author:MurakamiTakuy...lld:pubmed
pubmed-article:17697049pubmed:authorpubmed-author:KuramasuMahoMlld:pubmed
pubmed-article:17697049pubmed:authorpubmed-author:IijimaLeoLlld:pubmed
pubmed-article:17697049pubmed:issnTypePrintlld:pubmed
pubmed-article:17697049pubmed:volume102lld:pubmed
pubmed-article:17697049pubmed:ownerNLMlld:pubmed
pubmed-article:17697049pubmed:authorsCompleteYlld:pubmed
pubmed-article:17697049pubmed:pagination1635-44lld:pubmed
pubmed-article:17697049pubmed:dateRevised2009-11-19lld:pubmed
pubmed-article:17697049pubmed:meshHeadingpubmed-meshheading:17697049...lld:pubmed
pubmed-article:17697049pubmed:meshHeadingpubmed-meshheading:17697049...lld:pubmed
pubmed-article:17697049pubmed:meshHeadingpubmed-meshheading:17697049...lld:pubmed
pubmed-article:17697049pubmed:meshHeadingpubmed-meshheading:17697049...lld:pubmed
pubmed-article:17697049pubmed:meshHeadingpubmed-meshheading:17697049...lld:pubmed
pubmed-article:17697049pubmed:meshHeadingpubmed-meshheading:17697049...lld:pubmed
pubmed-article:17697049pubmed:meshHeadingpubmed-meshheading:17697049...lld:pubmed
pubmed-article:17697049pubmed:meshHeadingpubmed-meshheading:17697049...lld:pubmed
pubmed-article:17697049pubmed:meshHeadingpubmed-meshheading:17697049...lld:pubmed
pubmed-article:17697049pubmed:meshHeadingpubmed-meshheading:17697049...lld:pubmed
pubmed-article:17697049pubmed:meshHeadingpubmed-meshheading:17697049...lld:pubmed
pubmed-article:17697049pubmed:meshHeadingpubmed-meshheading:17697049...lld:pubmed
pubmed-article:17697049pubmed:year2007lld:pubmed
pubmed-article:17697049pubmed:articleTitleA novel PIP2 binding of epsilonPKC and its contribution to the neurite induction ability.lld:pubmed
pubmed-article:17697049pubmed:affiliationLaboratory of Molecular Pharmacology, Biosignal Research center, Kobe, Japan.lld:pubmed
pubmed-article:17697049pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:17697049pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17697049lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17697049lld:pubmed